CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
Mingyu Wei, 1 Zuowei Duan 2 1Medical College of Yangzhou University, Yangzhou 225000, Jiangsu, People’s Republic of China; 2Department of Neurology, The Affiliated Hospital of Yangzhou University, Yangzhou 225000, Jiangsu, People’s Republic of ChinaCorrespondence: Zuowei DuanEm...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/89e79d333dad47b78e07d4c5a2f24a8b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:89e79d333dad47b78e07d4c5a2f24a8b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:89e79d333dad47b78e07d4c5a2f24a8b2021-12-02T03:45:53ZCXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]1178-2021https://doaj.org/article/89e79d333dad47b78e07d4c5a2f24a8b2020-01-01T00:00:00Zhttps://www.dovepress.com/letter-cxcl13-is-a-biomarker-of-anti-leucine-rich-glioma-inactivated-p-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Mingyu Wei, 1 Zuowei Duan 2 1Medical College of Yangzhou University, Yangzhou 225000, Jiangsu, People’s Republic of China; 2Department of Neurology, The Affiliated Hospital of Yangzhou University, Yangzhou 225000, Jiangsu, People’s Republic of ChinaCorrespondence: Zuowei DuanEmail jydzw061344@163.comWe recently read the original report by Lin and colleagues with great interest. In this study, the authors concluded that both serum and cerebrospinal fluid (CSF) levels of CXCL13, a B cell chemotactic factor, were significantly higher in patients with anti-leucine-rich glioma-inactivated protein 1 (anti-LGI1) encephalitis compared to non-inflammatory neurologic disorder control groups. 1 However, we have some concerns about the interpretation of their data.View the original paper by Lin and colleagues.Wei MDuan ZDove Medical Pressarticlecxcl13anti-leucine-rich glioma-inactivated protein 1 encephalitisNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 181-182 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
cxcl13 anti-leucine-rich glioma-inactivated protein 1 encephalitis Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
cxcl13 anti-leucine-rich glioma-inactivated protein 1 encephalitis Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Wei M Duan Z CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter] |
| description |
Mingyu Wei, 1 Zuowei Duan 2 1Medical College of Yangzhou University, Yangzhou 225000, Jiangsu, People’s Republic of China; 2Department of Neurology, The Affiliated Hospital of Yangzhou University, Yangzhou 225000, Jiangsu, People’s Republic of ChinaCorrespondence: Zuowei DuanEmail jydzw061344@163.comWe recently read the original report by Lin and colleagues with great interest. In this study, the authors concluded that both serum and cerebrospinal fluid (CSF) levels of CXCL13, a B cell chemotactic factor, were significantly higher in patients with anti-leucine-rich glioma-inactivated protein 1 (anti-LGI1) encephalitis compared to non-inflammatory neurologic disorder control groups. 1 However, we have some concerns about the interpretation of their data.View the original paper by Lin and colleagues. |
| format |
article |
| author |
Wei M Duan Z |
| author_facet |
Wei M Duan Z |
| author_sort |
Wei M |
| title |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter] |
| title_short |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter] |
| title_full |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter] |
| title_fullStr |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter] |
| title_full_unstemmed |
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter] |
| title_sort |
cxcl13 is a biomarker of anti-leucine-rich glioma-inactivated protein 1 encephalitis patients [letter] |
| publisher |
Dove Medical Press |
| publishDate |
2020 |
| url |
https://doaj.org/article/89e79d333dad47b78e07d4c5a2f24a8b |
| work_keys_str_mv |
AT weim cxcl13isabiomarkerofantileucinerichgliomainactivatedprotein1encephalitispatientsletter AT duanz cxcl13isabiomarkerofantileucinerichgliomainactivatedprotein1encephalitispatientsletter |
| _version_ |
1718401636603265024 |